共 50 条
- [41] Reported Rates of Intraocular Inflammation with Intravitreal Aflibercept Administered via Pre-Filled Syringe or from Vials in Clinical Practice Between 2012 and 2022CLINICAL OPHTHALMOLOGY, 2023, 17 : 385 - 390Schmidt-Ott, UrsulaFitzpatrick, ScottHasanbasic, ZoranLeal, SergioMorgan-Warren, PeterZhang, XinJohnson, Kristian
- [42] Ranibizumab pre-filled syringe approved in the European Union: innovation to improve dose accuracy, reduce potential infection risk, and offer more efficient treatment administrationINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)Michaud, Jean-EricSigg, JuergenBoado, LinaMomm, JoachimWeber, CorneliaAlete, DanielPeregi, EvaPicci, Marie
- [43] CANAKINUMAB PRE-FILLED SYRINGE VS TRIAMCINOLONE ACETONIDE IN THE TREATMENT OF ACUTE GOUTY ARTHRITIS ATTACKS: RESULTS FROM A POST-HOC ANALYSIS IN DIFFICULT-TO-TREAT PATIENTSANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1083 - 1083Sunkureddi, P.Toth, E.Brown, J.Kivitz, A.Stancati, A.Richard, D.Lheritier, K.Moericke, R.
- [44] Efficacy, tolerability, patient usability, and satisfaction with a 2 mL pre-filled syringe containing secukinumab 300 mg in patients with moderate to severe plaque psoriasis: results from the phase 3 randomized, double-blind, placebo-controlled ALLURE studyJOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1718 - 1726Sigurgeirsson, BardurSchakel, KnutHong, Chih-HoEffendy, IsaakPlacek, WaldemarRich, PhoebeKeefe, DeborahBruin, GerardCharef, PascalFu, RongHampele, IsabellePatekar, Manmath
- [45] Secukinumab Self-Administration by Prefilled Syringe Maintains. Reduction of Plaque Psoriasis Severity Over 52 Weeks: Results of the FEATURE TrialJOURNAL OF DRUGS IN DERMATOLOGY, 2016, 15 (10) : 1226 - 1234Gottlieb, Alice B.Blauvelt, AndrewPrinz, Joerg C.Papanastasiou, PhilemonPathan, RashidkhanNyirady, JuditFox, ToddPapavassilis, Charis
- [46] A study model to investigate adherence to treatment among patients with relapsing-remitting multiple sclerosis initiating therapy with glatiramer acetate via pre-filled syringeMULTIPLE SCLEROSIS JOURNAL, 2005, 11 : S83 - S83Pardo, GSmith, SZwibel, HDenney, D
- [47] Usability of the Certolizumab Pegol Auto-Injection Device in Australian Patients with Chronic Rheumatic Diseases: Results from a Market Research StudyPATIENT PREFERENCE AND ADHERENCE, 2021, 15 : 1469 - 1476Aw, JuanGriffiths, HedleyZochling, JaneLanzafame, AlfredJordan, Andrew
- [48] Validation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability studyMEDICAL DEVICES-EVIDENCE AND RESEARCH, 2013, 6 (01) : 141 - 146Rapaport, RobertSaenger, PaulSchmidt, HeinrichHasegawa, YukihiroColle, MichelLoche, SandroMarcantonio, SandraBonfig, WalterZabransky, MarkusLifshitz, Fima
- [49] Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open-label, single-dose phase I studyEXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (07) : 681 - 689Yu, Kyung-SangRyu, HyunwookShin, DongseongPark, MinkyuHwang, JungiMoon, Seol JuKim, Min-GulKeystone, EdwardSmolen, Josef S.Kim, SunghyunBae, YunjuJeon, DabeeJang, JiyoungYang, GoeunBae, JihunLee, JaeyongBurmester, Gerd R.
- [50] Development of a novel auto-injector of subcutaneous CT-P13 infliximab: Phase I randomised, open-label, single-dose trial to compare the pharmacokinetics and safety to pre-filled syringe in healthy subjectsJOURNAL OF CROHNS & COLITIS, 2019, 13 : S458 - S459Schreiber, S.Ben-Horin, S.Ye, B. D.Westhovens, R.Yoo, D. H.Lee, S. J.Suh, J. H.Byeon, J. H.Reinisch, W.